Literature DB >> 32417227

Chronic Immune Activation in TB/HIV Co-infection.

Riti Sharan1, Allison N Bucşan2, Shashank Ganatra1, Mirko Paiardini3, Mahesh Mohan1, Smriti Mehra4, Shabaana A Khader5, Deepak Kaushal6.   

Abstract

HIV co-infection is the most critical risk factor for the reactivation of latent tuberculosis (TB) infection (LTBI). While CD4+ T cell depletion has been considered the major cause of HIV-induced reactivation of LTBI, recent work in macaques co-infected with Mycobacterium tuberculosis (Mtb)/simian immunodeficiency virus (SIV) suggests that cytopathic effects of SIV resulting in chronic immune activation and dysregulation of T cell homeostasis correlate with reactivation of LTBI. This review builds on compelling data that the reactivation of LTBI during HIV co-infection is likely to be driven by the events of HIV replication and therefore highlights the need to have optimum translational interventions directed at reactivation due to co-infection.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Mtb; SIV; chronic immune activation; co-infection; nonhuman primates

Mesh:

Year:  2020        PMID: 32417227      PMCID: PMC7390597          DOI: 10.1016/j.tim.2020.03.015

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  116 in total

1.  Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines.

Authors:  L A Falk; K L Goldenthal; J Esparza; M T Aguado; S Osmanov; W R Ballou; S Beddows; N Bhamarapravati; G Biberfeld; G Ferrari; D Hoft; M Honda; A Jackson; Y Lu; G Marchal; J McKinney; S Yamazaki
Journal:  AIDS Res Hum Retroviruses       Date:  2000-01-20       Impact factor: 2.205

2.  Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Authors:  Cecile Magis-Escurra; Gunar Günther; Christoph Lange; Sofia Alexandru; Neus Altet; Korkut Avsar; Didi Bang; Raisa Barbuta; Graham Bothamley; Ana Ciobanu; Valeriu Crudu; Manfred Davilovits; Martin Dedicoat; Raquel Duarte; Gina Gualano; Heike Kunst; Wiel de Lange; Vaira Leimane; Anne-Marie McLaughlin; Inge Muylle; Veronika Polcová; Christina Popa; Rudolf Rumetshofer; Alena Skrahina; Varvara Solodovnikova; Victor Spinu; Simon Tiberi; Piret Viiklepp; Frank van Leth
Journal:  Eur Respir J       Date:  2017-06-08       Impact factor: 16.671

3.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

4.  Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients.

Authors:  Z Toossi; H Mayanja-Kizza; C S Hirsch; K L Edmonds; T Spahlinger; D L Hom; H Aung; P Mugyenyi; J J Ellner; C W Whalen
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

5.  LAG3 expression in active Mycobacterium tuberculosis infections.

Authors:  Bonnie L Phillips; Smriti Mehra; Muhammad H Ahsan; Moises Selman; Shabaana A Khader; Deepak Kaushal
Journal:  Am J Pathol       Date:  2014-12-27       Impact factor: 4.307

6.  Tuberculosis Exacerbates HIV-1 Infection through IL-10/STAT3-Dependent Tunneling Nanotube Formation in Macrophages.

Authors:  Shanti Souriant; Luciana Balboa; Maeva Dupont; Karine Pingris; Denise Kviatcovsky; Céline Cougoule; Claire Lastrucci; Aicha Bah; Romain Gasser; Renaud Poincloux; Brigitte Raynaud-Messina; Talal Al Saati; Sandra Inwentarz; Susana Poggi; Eduardo Jose Moraña; Pablo González-Montaner; Marcelo Corti; Bernard Lagane; Isabelle Vergne; Carolina Allers; Deepak Kaushal; Marcelo J Kuroda; Maria Del Carmen Sasiain; Olivier Neyrolles; Isabelle Maridonneau-Parini; Geanncarlo Lugo-Villarino; Christel Vérollet
Journal:  Cell Rep       Date:  2019-03-26       Impact factor: 9.423

7.  Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico.

Authors:  Richard S Garfein; Rafael Laniado-Laborin; Timothy C Rodwell; Remedios Lozada; Robert Deiss; Jose Luis Burgos; Jazmine Cuevas-Mota; Paris Cerecer; Kathleen Moser; Maria Luisa Volker; Steffanie A Strathdee
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

8.  CXCR5⁺ T helper cells mediate protective immunity against tuberculosis.

Authors:  Samantha R Slight; Javier Rangel-Moreno; Radha Gopal; Yinyao Lin; Beth A Fallert Junecko; Smriti Mehra; Moises Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Lenin Pavon; Deepak Kaushal; Todd A Reinhart; Troy D Randall; Shabaana A Khader
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

9.  Viral load in tissues during the early and chronic phase of non-pathogenic SIVagm infection.

Authors:  A Gueye; O M Diop; M J Y Ploquin; C Kornfeld; A Faye; M-C Cumont; B Hurtrel; F Barré-Sinoussi; M C Müller-Trutwin
Journal:  J Med Primatol       Date:  2004-04       Impact factor: 0.667

10.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

View more
  5 in total

1.  Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis.

Authors:  Riti Sharan; Dhiraj Kumar Singh; Jyothi Rengarajan; Deepak Kaushal
Journal:  Front Immunol       Date:  2021-08-17       Impact factor: 8.786

2.  Genomic resources for rhesus macaques (Macaca mulatta).

Authors:  Jeffrey Rogers
Journal:  Mamm Genome       Date:  2022-01-09       Impact factor: 3.224

3.  Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model.

Authors:  Riti Sharan; Shashank R Ganatra; Allison N Bucsan; Journey Cole; Dhiraj K Singh; Xavier Alvarez; Maya Gough; Cynthia Alvarez; Alyssa Blakley; Justin Ferdin; Rajesh Thippeshappa; Bindu Singh; Ruby Escobedo; Vinay Shivanna; Edward J Dick; Shannan Hall-Ursone; Shabaana A Khader; Smriti Mehra; Jyothi Rengarajan; Deepak Kaushal
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 19.456

Review 4.  Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development.

Authors:  Shailja Jakhar; Alexis A Bitzer; Loreen R Stromberg; Harshini Mukundan
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923

Review 5.  Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety.

Authors:  Ronald N Kostoff; Darja Kanduc; Alan L Porter; Yehuda Shoenfeld; Daniela Calina; Michael B Briggs; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Toxicol Rep       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.